Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruixin Wu

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
ACS Nano|April 28, 2023
Biotin-Avidin System-Based Delivery Enhances the Therapeutic Performance of MSC-Derived ExosomesDaokun Deng, Xuan Li, Jiu-Jiu Zhang, et al.
Biomarker Research|June 30, 2026
TAF15-mediated m5C modification of MTHFD2 RNA reveals a novel therapeutic target for IDH mutant gliomasRuixin Wu, Licheng Zhang, Peter JihCheng Wong, et al.
Cancer Letters|May 17, 2021
Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancerJinbao Chen, Haijing Wang, Linlin Jia, et al.
Discover Oncology|May 11, 2025
Tumour-infiltrating immune cells as a novel prognostic model for bladder cancerCan Liu, Chaoyu Liao, Bishao Sun, et al.
Cell Reports|June 12, 2026
RBFOX2 suppresses NETosis and glioma growth via 5hmC-dependent PDGFB decayXi Chen, Weiwei Dai, Hanlin Wang, et al.
Discover Oncology|September 5, 2024
The role of KLF5 in gut microbiota and lung adenocarcinoma: unveiling programmed cell death pathways and prognostic biomarkersQingliang Fang, Meijun Xu, Wenyi Yao, et al.
Frontiers in Medicine|November 7, 2022
Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infectionSong Mu, Shuyi Song, Yanan Hao, et al.
Frontiers in Immunology|December 24, 2021
A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant StrainsFengxia Gao, Jingjing Huang, Tingting Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2024
NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasionRuixin Wu, Chunming Sun, Xi Chen, et al.
Frontiers in Immunology|April 8, 2021
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2Xiaojian Han, Yingming Wang, Shenglong Li, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
ACS Nano|April 28, 2023
Biotin-Avidin System-Based Delivery Enhances the Therapeutic Performance of MSC-Derived ExosomesDaokun Deng, Xuan Li, Jiu-Jiu Zhang, et al.
Biomarker Research|June 30, 2026
TAF15-mediated m5C modification of MTHFD2 RNA reveals a novel therapeutic target for IDH mutant gliomasRuixin Wu, Licheng Zhang, Peter JihCheng Wong, et al.
Cancer Letters|May 17, 2021
Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancerJinbao Chen, Haijing Wang, Linlin Jia, et al.
Discover Oncology|May 11, 2025
Tumour-infiltrating immune cells as a novel prognostic model for bladder cancerCan Liu, Chaoyu Liao, Bishao Sun, et al.
Cell Reports|June 12, 2026
RBFOX2 suppresses NETosis and glioma growth via 5hmC-dependent PDGFB decayXi Chen, Weiwei Dai, Hanlin Wang, et al.
Discover Oncology|September 5, 2024
The role of KLF5 in gut microbiota and lung adenocarcinoma: unveiling programmed cell death pathways and prognostic biomarkersQingliang Fang, Meijun Xu, Wenyi Yao, et al.
Frontiers in Medicine|November 7, 2022
Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infectionSong Mu, Shuyi Song, Yanan Hao, et al.
Frontiers in Immunology|December 24, 2021
A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant StrainsFengxia Gao, Jingjing Huang, Tingting Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2024
NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasionRuixin Wu, Chunming Sun, Xi Chen, et al.
Frontiers in Immunology|April 8, 2021
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2Xiaojian Han, Yingming Wang, Shenglong Li, et al.
Pageof 5